What is TFX's health score?

TELEFLEX INC (TFX) has a TradeApes health score of 41 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is TFX's estimated fair value?

Based on our 5-year discounted cash flow model, TELEFLEX INC's estimated fair value is $101.3 per share, representing a -20.6% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is TFX undervalued or overvalued?

Our model currently rates TFX as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for TFX... Refresh in a moment for the full analysis.

TELEFLEX INC (TFX)

Healthcare Overvalued low weak

$127.57

Updated: 2026-06-02

TradeApes Score

Financial Strength

35 Weak

Operating Trend

50 Mixed

Relative Value

30 Weak

Capital Allocation

45 Mixed

Risk

50 Mixed

Est. Fair Value $101.3

DCF Upside -20.6%

Sector Rank #1917 of 6611

Key Findings

+ Free cash flow positive — business generates real spendable cash

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.